2 assets in Juvenile Absence Epilepsy

Therapeutic assets addressing Juvenile Absence Epilepsy, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Brivaracetam Juvenile Absence Epilepsy	UCB Biopharma SRL	P3	B (60)
Brivaracetam Film-Coated Juvenile Absence Epilepsy	UCB Biopharma SRL	P3	B (60)